ScienceDex / Researcher record
Kexin Xu
- University of Virginia · Genetics (NIH department code)
From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.
- R01 Holder
- Early Career
NIH Funding · FY2026
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2024 | $1,000,416 | 4 | #15,004 |
| 2025 | $948,933 | 3 | #17,425 |
| 2026 | $424,908 | 1 | #36,577 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20244 records
- FY20253 records
- FY2026 · selected1 record
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 10424828Search this ID in NIH RePORTER
- ORCID iD
- https://orcid.org/0000-0002-2850-2083Verified identifier for this researcher
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2026 award categories
- Genetics
FY2026 award records by amount
NIH award records listing Kexin Xu as a PI. Multi-PI records show the full award amount for context.
- 5R01CA279681-03R01Contact PIFunction of the METTL3-NUP93 complex-mediated nuclear export of m6A-modified mRNAs in castration-resistant prostate cancer.University of Virginia · Genetics (NIH department code)$424.9Kaward amount
Award organization
Organizations that administered FY2026 awards listing Kexin Xu as a PI.
FY2026 award administered by University of Virginia (VA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardUniversity of Virginia
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2025R01 Grant Holder
- 2026$2M Cumulative Funding